Novartis Reports 10% Drop in Operating Profit, Net Income Falls 12.5%

Swiss pharmaceutical giant Novartis reported a decline in operating profit of more than 10% in its latest quarterly results. The company's net income reached $3.16 billion, representing a 12.5% decrease compared to the same period last year. The earnings decline reflects challenges facing the global pharmaceutical industry amid economic pressures and changing market conditions.